http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101189327-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_77f1ebca298a07d78f3d32e7a96ef6d9 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0797 |
| filingDate | 2006-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_474bde0d1554242039035da76cc92abc |
| publicationDate | 2008-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-101189327-A |
| titleOfInvention | A human immortalised neural precursor cell line |
| abstract | The present invention relates to an immortalised human neural precursor cell line, NGC-407. The cell line has been established from human foetal tissue. The cell line has been immortalised using a retroviral vector containing the v-myc oncogene. The cell line is a neural progenitor cell line capable of differentiating into to astrocytes and neurons including dopaminergic neurons. NGC-407 cells are capable of migrating to glioblastoma tumours implanted into rat brains and form gap junctions with the tumour cells. NGC-407 cells expressing a suicide gene can be be used for delivering activated prodrugs in the form of activated nucleoside analogs to tumours. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103343108-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107429234-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114657167-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114657167-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103343108-B |
| priorityDate | 2005-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1184.